David focuses on U.S. securities law and capital market transactions. He advises technology and pharmaceutical companies and provides counsel on all aspects of U.S. corporate and securities law, including public offerings. He provides ongoing advice to numerous Israeli companies listed on Nasdaq.

*David is a partner with the Israel law firm, Har-Even & Co., which is affiliated with Sullivan & Worcester LLP.

Representative Client Work

  • Represented Nano Dimension Ltd. in several offerings of American Depositary Shares – $13.3 million (April 2020), $3.9 million (February 2020), $13 million (February 2018), $12 million (February 2019), and a debt offering of $7 million (September 2019)
  • Represented Safe-T Group Ltd. in its $8.4 million public offering of American Depositary Shares and Warrants in April 2020, its $10 million initial public offering and dual listing on the Nasdaq Capital Market, its acquisition of Net Nut Ltd. in June 2019, and debt offering of $5 million in June 2019
  • Represented Foresight Autonomous Holdings Ltd. in a $20 million private placement of NIS in June 2018, and a $6.2 million offering of American Depositary Shares in March 2019
  • Represented Therapix Biosciences Ltd. in its U.S. initial public offering, including its dual listing on Nasdaq
  • Represented Radcom Ltd. in two public offerings of ordinary shares (October 2017; $28 million and May 2016; $20 million)
  • Represented an investment bank as underwriter in a public offering
  • Represented Bioblast Pharma Ltd. in its registered direct offering of ordinary shares
  • Represented On Track Innovations Ltd. in its public offering of ordinary shares

Bar & Court Admissions

  • Israel
  • Illinois


  • J.D., magna cum laude, Chicago Kent College of Law
  • B.A., magna cum laude, Bradley University 

Community Engagement

  • Israeli Bar Association


  • English
  • Hebrew



Jump to Page